Bastide le Confort Medical (BLC) AI Stock Analysis

• Market Cap: €135.14M
• Dividend Yield: 0.58%
• Average Volume (3M): 3.45K
• Price to Earnings (P/E): 4.6
• Beta (1Y): 0.58
• Revenue Growth: -11.89%
• EPS Growth: 1623.56%
• Country: FR
• Employees: 3,641
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Care Facilities
• EPS (TTM): 4.00
• Shares Outstanding: 7,365,078
• 10 Day Avg. Volume: 4,124
• 30 Day Avg. Volume: 3,454
• PEG Ratio: <0.01
• Price to Book (P/B): 1.33
• Price to Sales (P/S): 0.36
• P/FCF Ratio: 5.65
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 1.85
• Revenue Forecast (FY): €511.00M

• Rating: 49 Neutral
• Price Target: €27.00 ▲(22.73% Upside)
• Action: Reiterated
• Date: 12/11/25

Positive Factors

High gross & EBITDA margins

Sustained high gross (≈68%) and EBITDA (20.8%) margins reflect durable operational efficiency and pricing power in device distribution and services. These margins provide a structural cushion against revenue volatility, support reinvestment in network and services, and help preserve cash generation even if top-line growth slows.

Negative Factors

Declining revenue growth

A sustained decline in revenue (reported -9.1%) erodes scale benefits and pressures fixed-cost absorption. Over months this reduces leverage on strong gross margins, constrains capacity to invest in branches or services, and raises the bar for management to restore organic growth or offset with acquisitions.

Bastide le Confort Medical Business Overview & Revenue Model

Company Description

Bastide Le Confort Médical SA specializes in the provision, through both sales and rentals, of medical equipment across France. The company offers a comprehensive array of items, encompassing comfort and wellness products such as specialized seati...

Read more

Bastide Le Confort Médical SA specializes in the provision, through both sales and rentals, of medical equipment across France. The company offers a comprehensive array of items, encompassing comfort and wellness products such as specialized seati...

How the Company Makes Money

BLC makes money primarily by providing homecare therapies and by supplying medical equipment and consumables to patients in the home setting. Key revenue streams typically include: (1) recurring revenues from long-term homecare programs (e.g., res...

Read more

BLC makes money primarily by providing homecare therapies and by supplying medical equipment and consumables to patients in the home setting. Key revenue streams typically include: (1) recurring revenues from long-term homecare programs (e.g., res...

Bastide le Confort Medical Financial Statement Overview

Breakdown	TTM	Jun 2026	Sep 2025	Sep 2024	Jun 2023	Jun 2022
Income Statement
Total Revenue	476.02M	482.39M	491.18M	529.75M	508.03M	468.30M
Gross Profit	49.09M	50.87M	333.00M	354.44M	333.73M	306.80M
EBITDA	98.75M	104.85M	102.03M	107.20M	98.15M	89.83M
Net Income	29.45M	58.10M	528.00K	-900.00K	12.05M	13.68M
Balance Sheet
Total Assets	580.52M	575.80M	661.03M	647.07M	657.08M	632.55M
Cash, Cash Equivalents and Short-Term Investments	25.47M	48.21M	25.49M	23.62M	36.71M	22.13M
Total Debt	324.13M	299.13M	411.16M	408.65M	427.39M	419.23M
Total Liabilities	478.08M	444.98M	589.73M	566.34M	568.99M	545.89M
Stockholders Equity	102.75M	131.07M	72.13M	79.77M	87.65M	84.56M
Cash Flow
Free Cash Flow	29.93M	30.77M	41.74M	10.64M	36.65M	-6.51M
Operating Cash Flow	78.98M	81.78M	101.82M	66.04M	90.28M	46.76M
Investing Cash Flow	27.86M	60.08M	-56.44M	-43.65M	-76.27M	-104.74M
Financing Cash Flow	-102.88M	-118.31M	-4.33M	-35.55M	-7.89M	29.43M

Bastide le Confort Medical Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 22.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:BLC, the sentiment is Neutral. The current price of 22 is above the 20-day moving average (MA) of 18.81, above the 50-day MA of 20.84, and below the 200-day MA of 23.47, indicating a neutral trend. The MACD of -0.74 indicates Negative momentum. The RSI at 46.22 is Neutral, neither overbought nor oversold. The STOCH value of 29.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:BLC.

Bastide le Confort Medical Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BOI	74 Outperform	€314.46M	12.05	6.82%	7.52%	-1.80%	35.22%
AI	73 Outperform	€109.70B	29.73	13.42%	1.76%	-1.30%	3.05%
BIM	61 Neutral	€10.18B	21.95	11.01%	1.14%	-3.18%	22.52%
ALCGM	60 Neutral	€143.18M	-9.83	-5.44%	2.17%	-0.98%	―
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
BLC	49 Neutral	€135.14M	4.62	49.70%	0.58%	-11.89%	1623.56%
VTR	38 Underperform	€43.34M	-1.27	-15.20%	1.38%	8.96%	41.13%